Identification | Back Directory | [Name]
Methyl 2-(bromomethyl)-4-methoxybenzoate | [CAS]
15365-25-0 | [Synonyms]
NISTC15365250 METHYL 2-BROMOMETHYL-4-METHOXY-BENZOATE p-Anisic acid, 2-bromomethyl-, methyl ester 2-BROMOMETHYL-4-METHOXYBENZOICACID,METHYLESTER Benzoic acid, 2-(broMoMethyl)-4-Methoxy-, Methyl ester | [Molecular Formula]
C10H11BrO3 | [MDL Number]
MFCD04114316 | [MOL File]
15365-25-0.mol | [Molecular Weight]
259.1 |
Chemical Properties | Back Directory | [Melting point ]
51 °C | [Boiling point ]
350.4±32.0 °C(Predicted) | [density ]
1.432±0.06 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [Appearance]
White to off-white Solid |
Hazard Information | Back Directory | [Uses]
Methyl 2-(bromomethyl)-4-methoxybenzoate | [Synthesis]
The general procedure for the synthesis of methyl 2-bromomethyl-4-methoxybenzoate from methyl 4-methoxy-2-methylbenzoate was as follows: N-bromosuccinimide (1.1 g, 6.2 mmol) and a catalytic amount of methyl 4-methoxy-2-methylbenzoate (1 g, 5.6 mmol) were pre-dissolved in carbon tetrachloride (5 mL), which was subsequently added dropwise to a solution containing 25 mL of carbon tetrachloride. After addition of benzoyl peroxide, the reaction mixture was refluxed for 2 hours. After completion of the reaction, it was cooled to room temperature and the mixture was poured into ice water. The aqueous phase was extracted with dichloromethane (3×), and the combined organic phases were dried over magnesium sulfate, filtered, and concentrated under vacuum to afford 2.1 g of the target product, methyl 2-bromomethyl-4-methoxybenzoate, as a light yellow solid in about 100% yield. Mass spectrometry analysis showed [M + H+] m/z 260. | [References]
[1] Patent: WO2011/85261, 2011, A1. Location in patent: Page/Page column 36 [2] Patent: WO2011/85128, 2011, A1. Location in patent: Page/Page column 56 [3] Journal of Medicinal Chemistry, 1987, vol. 30, # 10, p. 1798 - 1806 [4] Patent: US2008/249101, 2008, A1. Location in patent: Page/Page column 40 [5] Patent: WO2008/20306, 2008, A2. Location in patent: Page/Page column 35 |
|
Company Name: |
Tetranov Biopharm
|
Tel: |
13526569071 |
Website: |
http://www.leadmedpharm.com/index.html |
|